Mosby's 2023 Nursing Drug Reference

Mosby's 2023 Nursing Drug Reference

Skidmore-Roth, Linda

Elsevier - Health Sciences Division

07/2022

1504

Mole

Inglês

9780323930727

15 a 20 dias

1110

Descrição não disponível.
INDIVIDUAL DRUG MONOGRAPHS
APPENDIXES
A. Selected New Drugs
abametapir
aducanumab-avwa
afamelanotide
anifrolumab-fnia
asciminib
atogepant
avacopan
avapritinib
belumosudil
belzutifan
bempedoic acid
brolucizumab-dbll
difelikefalin
dostarlimab-gxly
eculizumab
efavirenz/emtricitabine/tenofovir
elapegademase-ivir
elbasvir/grazoprevir
elexacaftor/tezacaftor/ivacaftor and ivacaftor
emtricitabine/rilpivirine/tenofovir alafenamide
enalapril/hydrochlorothiazide
ephedrine
factor IX complex
factor IX, human
factor IX, recombinant
finerenone
fluocinolone
fluocinonide
lonapegsomatropin-tcgd
loncastuximab tesirine-lpyl
maribavir
mobocertinib
odevixibat
ropeginterferon alfa-2b
tisotumab vedotin-tftv
vosoritide
B. Ophthalmic, Nasal, Topical, and Otic Products
C. Vaccines and Toxoids
D. Recent FDA Drug Approvals
INDEX
EVOLVE WEBSITE
. Additional Monographs
. Drug Categories
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
<P>Skidmore; NDR; drug reference; drug safety; nursing; nursing students</P>